Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Novel Anticancer Quinolone, ( R )-Wac-224 Monotherapy or Combination with Cytarabine/Venetoclax Confers Promising Activities Against Acute Myeloid Leukemia

Tatsuji Mino, Hiroshi Ureshino, Taichi Ueshima, Naoki Kashimoto, Tomonori Yamaguchi, Miyuki Takashima, Yusuke Sanuki, Kazuhito Naka, Toshiya Inaba, Tatsuo Ichinohe

Blood (2023) 142 (Supplement 1): 5775.

https://doi.org/10.1182/blood-2023-175075

Published: 2023

Journal Articles

mTORC1 Inactivation Prevents and Eradicates Acute Lymphoblastic T-Cell Leukemia

Takayuki Hoshii, Ph.D., Atsuo Kasada, MD, Tomoki Hatakeyama, Masashi Ohtani, Ph.D., Yuko Tadokoro, Ph.D., Kazuhito Naka, Ph.D., Tsuneo Ikenoue, MD., Ph.D., Tomokatsu Ikawa, Ph.D., Hiroshi Kawamoto, MD., Ph.D., Kimi Araki, Ph.D., Ken-ichi Yamamura, MD., Ph.D., Atsushi Iwama, MD., Ph.D., Satoshi Matsuda, MD., Ph.D., Atsushi Hirao, MD., Ph.D.

Blood (2013) 122 (21): 1211.

https://doi.org/10.1182/blood.V122.21.1211.1211

Published: 2013

Journal Articles

Regulatory Role of Host IL-17 Via Control of Host Macrophage Activation Contributes to Less Acute Gvhd

Rie Kuroda, MD, Katsuaki Sato, MD, PhD, Hideaki Maeba, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Kazuhito Naka, PhD, Makoto Naito, MD. PhD, Yoichiro Iwakura, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4669.

https://doi.org/10.1182/blood.V120.21.4669.4669

Published: 2012

Journal Articles

Both Tissue-Derived and Bone Marrow-Derived Host IL-17 Producing Cells Are Required for Preventing Acute Graft-Versus-Host Disease

Rie Kuroda, MD, Hideaki Maeba, MD, Katsuaki Sato, MD, PhD, Kazuhito Naka, PhD, Shintaro Mase, MD, Raita Araki, MD, Toshihiro Fujiki, MD, Yoichiro Iwakura, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2011) 118 (21): 2970.

https://doi.org/10.1182/blood.V118.21.2970.2970

Published: 2011

Journal Articles

Molecular Mechanism Regulating Foxo In Leukemia Initiating Cells of Chronic Myeloid Leukemia.

Kazuhito Naka, Ph.D., Takayuki Hoshii, Ph.D., Yuko Tadokoro, Ph.D., Takako Ooshio, Ph.D., Yukio Kondo, M.D.Ph.D., Shinji Nakao, MD, PhD, Noboru Motoyama, Ph.D., Atsushi Hirao, M.D.Ph.D.

Blood (2010) 116 (21): 3391.

https://doi.org/10.1182/blood.V116.21.3391.3391

Published: 2010

Journal Articles

Cytokine-Induced Killer Cells Facilitate Immune Reconstitution After Allogeneic BMT In Mice.

Shintaro Mase, MD, Ryosei Nishimura, MD, PhD, Rie Kuroda, MD, Hideaki Maeba, MD, Kazuhito Naka, Raita Araki, MD, Yasuhiro Ikawa, MD, PhD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD

Blood (2010) 116 (21): 3719.

https://doi.org/10.1182/blood.V116.21.3719.3719

Published: 2010

Journal Articles

Role of Il-17 Varies at Different Periods After Hematopoietic Stem Cell Transplantation: Protection From Acute Graft-Versus-Host Disease and Exacerbation of Chronic Graft-Versus-Host Disease.

Rie Kuroda, MD, Ryosei Nishimura, MD, PhD, Katsuaki Sato, MD, Hideaki Maeba, MD, Kazuhito Naka, PhD, Shintaro Mase, MD, Raita Araki, MD, Yasuhiro Ikawa, MD, PhD, Yoichiro Iwakura, PhD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD

Blood (2010) 116 (21): 3741.

https://doi.org/10.1182/blood.V116.21.3741.3741

Published: 2010

Journal Articles

Donor Bone Marrow Derived IL-17 Expressing Cells Exacerbate Chronic Graft-Versus-Host Disease in a Murine Bone Marrow Transplantation.

Rie Kuroda, MD, Ryosei Nishimura, MD, PhD, Katsuaki Sato, MD, PhD, Hideaki Maeba, MD, Kazuhito Naka, PhD, Yo Niida, MD, PhD, Raita Araki, MD, Yoichiro Iwakura, PhD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD

Blood (2008) 112 (11): 2345.

https://doi.org/10.1182/blood.V112.11.2345.2345

Published: 2008

Journal Articles

Establishment of a Labeling System for Hematopoietic Stem Cells by Nucleostemin Enhancer/Promoter-GFP Transgenic Mice.

Kazuhito Naka, Masako Ohmura, Toshio Suda, Atsushi Hirao

Blood (2007) 110 (11): 2240.

https://doi.org/10.1182/blood.V110.11.2240.2240

Published: 2007

Journal Articles

Foxo3a Is Essential for the Quiescence and Self-Renewal of Hematopoietic Stem Cells.

Kana Miyamoto, MD, Atsushi Hirao, M.D., Ph.D., Kiyomi Y. Araki, Ph.D., Fumio Arai, Ph.D., Kazuhito Naka, Ph.D., Keiyo Takubo, M.D., Sahoko Matsuoka, M.D., Ph.D., Satoshi Yamazaki, Keisuke Ito, M.D., Ph.D., Masako Ohmura, Ph.D., Kentaro Hosokawa, Mine Harada, M.D., Ph.D., Noboru Motoyama, Ph.D., Toshio Suda, M.D., Ph.D.

Blood (2006) 108 (11): 442.

https://doi.org/10.1182/blood.V108.11.442.442

Published: 2006

NARROW

A Novel Anticancer Quinolone, ( R )-Wac-224 Monotherapy or Combination with Cytarabine/Venetoclax Confers Promising Activities Against Acute Myeloid Leukemia

mTORC1 Inactivation Prevents and Eradicates Acute Lymphoblastic T-Cell Leukemia

Regulatory Role of Host IL-17 Via Control of Host Macrophage Activation Contributes to Less Acute Gvhd

Both Tissue-Derived and Bone Marrow-Derived Host IL-17 Producing Cells Are Required for Preventing Acute Graft-Versus-Host Disease

Molecular Mechanism Regulating Foxo In Leukemia Initiating Cells of Chronic Myeloid Leukemia.

Cytokine-Induced Killer Cells Facilitate Immune Reconstitution After Allogeneic BMT In Mice.

Role of Il-17 Varies at Different Periods After Hematopoietic Stem Cell Transplantation: Protection From Acute Graft-Versus-Host Disease and Exacerbation of Chronic Graft-Versus-Host Disease.

Donor Bone Marrow Derived IL-17 Expressing Cells Exacerbate Chronic Graft-Versus-Host Disease in a Murine Bone Marrow Transplantation.

Establishment of a Labeling System for Hematopoietic Stem Cells by Nucleostemin Enhancer/Promoter-GFP Transgenic Mice.

Foxo3a Is Essential for the Quiescence and Self-Renewal of Hematopoietic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only